FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3012466915> ?p ?o ?g. }

• W3012466915 endingPage "486" @default.
• W3012466915 startingPage "478" @default.
• W3012466915 abstract "To determine the recommended phase 2 dose of RRx-001, a radiosensitizer with vascular normalizing properties, when used with whole-brain radiation therapy (WBRT) for brain metastases and to assess whether quantitative changes in perfusion magnetic resonance imaging (MRI) after RRx-001 correlate with response.Five centers participated in this phase 1/2 trial of RRx-001 given once pre-WBRT and then twice weekly during WBRT. Four dose levels were planned (5 mg/m2, 8.4 mg/m2, 16.5 mg/m2, 27.5 mg/m2). Dose escalation was managed by the time-to-event continual reassessment method algorithm. Linear mixed models were used to correlate change in 24-hour T1, Ktrans (capillary permeability), and fractional plasma volume with change in tumor volume.Between 2015 and 2017, 31 patients were enrolled. Two patients dropped out before any therapy. Median age was 60 years (range, 30-76), and 12 were male. The most common tumor types were melanoma (59%) and non-small cell lung cancer (18%). No dose limiting toxicities were observed. The most common severe adverse event was grade 3 asthenia (6.9%, 2 of 29). The median intracranial response rate was 46% (95% confidence interval, 24-68) and median overall survival was 5.2 months (95% confidence interval, 4.5-9.4). No neurologic deaths occurred. Among 10 patients undergoing dynamic contrast-enhanced MRI, a reduction in Vp 24 hours after RRx-001 was associated with reduced tumor volume at 1 and 4 months (P ≤ .01).The addition of RRx-001 to WBRT is well tolerated with favorable intracranial response rates. Because activity was observed across all dose levels, the recommended phase 2 dose is 10 mg twice weekly. A reduction in fractional plasma volume on dynamic contrast-enhanced MRI 24 hours after RRx-001 suggests antiangiogenic activity associated with longer-term tumor response." @default.
• W3012466915 created "2020-03-23" @default.
• W3012466915 creator A5001497458 @default.
• W3012466915 creator A5004681706 @default.
• W3012466915 creator A5014527725 @default.
• W3012466915 creator A5020712237 @default.
• W3012466915 creator A5021609838 @default.
• W3012466915 creator A5031640214 @default.
• W3012466915 creator A5034370633 @default.
• W3012466915 creator A5046132413 @default.
• W3012466915 creator A5052914934 @default.
• W3012466915 creator A5053441903 @default.
• W3012466915 creator A5060316016 @default.
• W3012466915 creator A5060495866 @default.
• W3012466915 creator A5061660342 @default.
• W3012466915 creator A5063863193 @default.
• W3012466915 creator A5066404810 @default.
• W3012466915 creator A5067646281 @default.
• W3012466915 creator A5070141227 @default.
• W3012466915 creator A5070289110 @default.
• W3012466915 creator A5076238068 @default.
• W3012466915 creator A5091692503 @default.
• W3012466915 date "2020-07-01" @default.
• W3012466915 modified "2023-10-17" @default.
• W3012466915 title "BRAINSTORM: A Multi-Institutional Phase 1/2 Study of RRx-001 in Combination With Whole Brain Radiation Therapy for Patients With Brain Metastases" @default.
• W3012466915 cites W1966822881 @default.
• W3012466915 cites W1982217620 @default.
• W3012466915 cites W1993576555 @default.
• W3012466915 cites W2002834275 @default.
• W3012466915 cites W2003917401 @default.
• W3012466915 cites W2031982747 @default.
• W3012466915 cites W2042098439 @default.
• W3012466915 cites W2043166238 @default.
• W3012466915 cites W2063999920 @default.
• W3012466915 cites W2067893090 @default.
• W3012466915 cites W2076981660 @default.
• W3012466915 cites W2087704303 @default.
• W3012466915 cites W2102348938 @default.
• W3012466915 cites W2103802402 @default.
• W3012466915 cites W2126022863 @default.
• W3012466915 cites W2128871519 @default.
• W3012466915 cites W2133350192 @default.
• W3012466915 cites W2143843774 @default.
• W3012466915 cites W2145376545 @default.
• W3012466915 cites W2150405633 @default.
• W3012466915 cites W2158789700 @default.
• W3012466915 cites W2167228337 @default.
• W3012466915 cites W2177244913 @default.
• W3012466915 cites W2265878630 @default.
• W3012466915 cites W2384087620 @default.
• W3012466915 cites W2492450141 @default.
• W3012466915 cites W2587681779 @default.
• W3012466915 cites W2792489739 @default.
• W3012466915 cites W2801858894 @default.
• W3012466915 cites W2922208960 @default.
• W3012466915 cites W4212948410 @default.
• W3012466915 cites W770767527 @default.
• W3012466915 doi "https://doi.org/10.1016/j.ijrobp.2020.02.639" @default.
• W3012466915 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32169409" @default.
• W3012466915 hasPublicationYear "2020" @default.
• W3012466915 type Work @default.
• W3012466915 sameAs 3012466915 @default.
• W3012466915 citedByCount "6" @default.
• W3012466915 countsByYear W30124669152021 @default.
• W3012466915 countsByYear W30124669152022 @default.
• W3012466915 countsByYear W30124669152023 @default.
• W3012466915 crossrefType "journal-article" @default.
• W3012466915 hasAuthorship W3012466915A5001497458 @default.
• W3012466915 hasAuthorship W3012466915A5004681706 @default.
• W3012466915 hasAuthorship W3012466915A5014527725 @default.
• W3012466915 hasAuthorship W3012466915A5020712237 @default.
• W3012466915 hasAuthorship W3012466915A5021609838 @default.
• W3012466915 hasAuthorship W3012466915A5031640214 @default.
• W3012466915 hasAuthorship W3012466915A5034370633 @default.
• W3012466915 hasAuthorship W3012466915A5046132413 @default.
• W3012466915 hasAuthorship W3012466915A5052914934 @default.
• W3012466915 hasAuthorship W3012466915A5053441903 @default.
• W3012466915 hasAuthorship W3012466915A5060316016 @default.
• W3012466915 hasAuthorship W3012466915A5060495866 @default.
• W3012466915 hasAuthorship W3012466915A5061660342 @default.
• W3012466915 hasAuthorship W3012466915A5063863193 @default.
• W3012466915 hasAuthorship W3012466915A5066404810 @default.
• W3012466915 hasAuthorship W3012466915A5067646281 @default.
• W3012466915 hasAuthorship W3012466915A5070141227 @default.
• W3012466915 hasAuthorship W3012466915A5070289110 @default.
• W3012466915 hasAuthorship W3012466915A5076238068 @default.
• W3012466915 hasAuthorship W3012466915A5091692503 @default.
• W3012466915 hasBestOaLocation W30124669151 @default.
• W3012466915 hasConcept C126322002 @default.
• W3012466915 hasConcept C126838900 @default.
• W3012466915 hasConcept C143409427 @default.
• W3012466915 hasConcept C143998085 @default.
• W3012466915 hasConcept C197934379 @default.
• W3012466915 hasConcept C2776256026 @default.
• W3012466915 hasConcept C2989005 @default.
• W3012466915 hasConcept C44249647 @default.
• W3012466915 hasConcept C509974204 @default.
• W3012466915 hasConcept C71924100 @default.

• next